Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: Findings from the Guthrie Health Off-Label Stent (GHOST) investigators

Journal of Interventional Cardiology

Volumn 25, Issue 3, 2012, Pages 262-269

  Singla, Anand ^a   Orshaw, Pamela ^a   Boura, Judy ^a   Harjai, Kishore J ^a,b  

^a GUTHRIE RESEARCH INSTITUTE   (United States)

^b Cardiac and Vascular Center of Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ACUTE HEART INFARCTION; ARTICLE; BLOOD VESSEL DIAMETER; CORONARY STENT; DIABETIC PATIENT; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84862269203     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00715.x     Document Type: Article

References (18)

1. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous coronary angioplasty. Circulation 1995;9:979-989.
2. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589. (Pubitemid 28435240)
3. Harjai KJ, Stone GW, Boura J, et al. Primary angioplasty in myocardial infarction investigators. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction.AmJ Cardiol 2003;91:1041-1045. (Pubitemid 36514916)
4. De Luca G, Sauro R, Varricchio A, et al. Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES. J Thromb Thrombolysis 2010;30:133-141.
5. Ishihara M, Kagawa E, Inoue I, et al. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007;99:1674-1679. (Pubitemid 46874310)
6. Ga̧sior M, Stasik-Pres G, Pres D, et al. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol 2007;65:1031-1038. (Pubitemid 350096908)
7. Svensson AM, McGuire DK, Abrahamsson P, et al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J, 2005;26:1255-1256.
8. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-2632. (Pubitemid 29237448)
9. Hadjadj S, Coisne D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004;21:305-310. (Pubitemid 38519663)
10. Cakmak M, Cakmak N, Cetemen S, et al. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol 2008;24:375-378. (Pubitemid 351877356)
11. Husband DJ, Alberti KG, Julian DG, et al. "Stress" hyperglycaemia during acute myocardial infarction: An indicator of pre-existing diabetes? Lancet 1983;2:179-181. (Pubitemid 13069488)
12. Corpus RA, George PB, House JA, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004;43:8-14. (Pubitemid 38045906)
13. Hill ME, Rosenwaike I. The Social Security Administration's Death Master File: The completeness of death reporting at older ages. Soc Secur Bull 2001;64:45-51
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553 (Pubitemid 28319935)
15. American Diabetes Association. Clinical practice recommendations 2001. Diabetes Care 2001;24(Suppl 1):S1-133.
16. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
17. Zhang Q, Shen J, Zhang RY, et al. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevationmyocardial infarction. Chin Med J (Engl). 2007;120:1862-1867. (Pubitemid 350111057)
18. Gurbel PA, Bliden KP, Hiatt BL, et al., Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2013.